{
    "nctId": "NCT04824027",
    "briefTitle": "Breast Elasticity Imaging During Neoadjuvant Chemotherapy",
    "officialTitle": "Predicting Response to Neoadjuvant Chemotherapy Using Harmonic Motion Imaging in Women With Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Assessment of the correlation between change in HMI measurements and pathologic response at completion of neoadjuvant therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women age \u226518\n* Deemed eligible to receive neoadjuvant systemic therapy as per the treating physician, with the dose and schedule deemed appropriate by the treating physician.\n* Any stage invasive breast cancer provided the primary breast tumor size is \u2265 4 mm\n\nExclusion criteria:\n\n* Patient is pregnant or lactating\n* Presence of breast implants\n* History of laser or radiation therapy to the affected breast",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}